APA

Onaivi E. S., Benno R., Halpern T., Mehanovic M., Schanz N., Sanders C., Yan X., Ishiguro H., Liu Q., Berzal A. L., Viveros M. P. & Ali S. F. (20111110). Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders. : Current neuropharmacology.

Chicago

Onaivi E S, Benno R, Halpern T, Mehanovic M, Schanz N, Sanders C, Yan X, Ishiguro H, Liu Q-R, Berzal A L, Viveros M P and Ali S F. 20111110. Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders. : Current neuropharmacology.

Harvard

Onaivi E. S., Benno R., Halpern T., Mehanovic M., Schanz N., Sanders C., Yan X., Ishiguro H., Liu Q., Berzal A. L., Viveros M. P. and Ali S. F. (20111110). Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders. : Current neuropharmacology.

MLA

Onaivi E S, Benno R, Halpern T, Mehanovic M, Schanz N, Sanders C, Yan X, Ishiguro H, Liu Q-R, Berzal A L, Viveros M P and Ali S F. Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders. : Current neuropharmacology. 20111110.